ALZN
Price
$1.16
Change
+$0.01 (+0.87%)
Updated
Jan 17 closing price
Capitalization
6.3M
SRPT
Price
$118.00
Change
+$0.94 (+0.80%)
Updated
Jan 17 closing price
Capitalization
11.27B
45 days until earnings call
Ad is loading...

ALZN vs SRPT

Header iconALZN vs SRPT Comparison
Open Charts ALZN vs SRPTBanner chart's image
Alzamend Neuro
Price$1.16
Change+$0.01 (+0.87%)
Volume$57.48K
Capitalization6.3M
Sarepta Therapeutics
Price$118.00
Change+$0.94 (+0.80%)
Volume$649.14K
Capitalization11.27B
ALZN vs SRPT Comparison Chart
Loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALZN vs. SRPT commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a Hold and SRPT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ALZN: $1.16 vs. SRPT: $118.00)
Brand notoriety: ALZN: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 39% vs. SRPT: 68%
Market capitalization -- ALZN: $6.3M vs. SRPT: $11.27B
ALZN [@Biotechnology] is valued at $6.3M. SRPT’s [@Biotechnology] market capitalization is $11.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 1 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • ALZN’s FA Score: 1 green, 4 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, ALZN is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 2 TA indicator(s) are bullish while SRPT’s TA Score has 5 bullish TA indicator(s).

  • ALZN’s TA Score: 2 bullish, 4 bearish.
  • SRPT’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than ALZN.

Price Growth

ALZN (@Biotechnology) experienced а +2.65% price change this week, while SRPT (@Biotechnology) price change was -5.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ALZN is expected to report earnings on Jan 03, 2024.

SRPT is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($11.3B) has a higher market cap than ALZN($6.3M). ALZN YTD gains are higher at: 0.000 vs. SRPT (-2.953). SRPT has higher annual earnings (EBITDA): 187M vs. ALZN (-5.78M). SRPT has more cash in the bank: 1.2B vs. ALZN (4.09M). ALZN has less debt than SRPT: ALZN (345K) vs SRPT (1.4B). SRPT has higher revenues than ALZN: SRPT (1.64B) vs ALZN (0).
ALZNSRPTALZN / SRPT
Capitalization6.3M11.3B0%
EBITDA-5.78M187M-3%
Gain YTD0.000-2.953-
P/E RatioN/A76.62-
Revenue01.64B-
Total Cash4.09M1.2B0%
Total Debt345K1.4B0%
FUNDAMENTALS RATINGS
SRPT: Fundamental Ratings
SRPT
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
62
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALZNSRPT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
80%
Momentum
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
76%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
72%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 13 days ago
75%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 20 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
71%
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZOM0.13N/A
+2.53%
Zomedica Corp
ATMU42.210.43
+1.03%
Atmus Filtration Technologies
EVTL9.290.07
+0.76%
Vertical Aerospace Ltd
EDSA1.700.01
+0.60%
Edesa Biotech
RDY14.900.07
+0.47%
Dr. Reddy's Laboratories Ltd

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
+0.87%
SRPT - ALZN
49%
Loosely correlated
+0.80%
NCNA - ALZN
45%
Loosely correlated
+2.70%
VRAX - ALZN
41%
Loosely correlated
+1.87%
SNSE - ALZN
41%
Loosely correlated
+4.17%
BPMUF - ALZN
36%
Loosely correlated
N/A
More

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with TECX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
+0.80%
TECX - SRPT
59%
Loosely correlated
-2.67%
GLMD - SRPT
51%
Loosely correlated
-1.02%
ALZN - SRPT
49%
Loosely correlated
+0.87%
XBIO - SRPT
48%
Loosely correlated
-0.31%
BMRN - SRPT
45%
Loosely correlated
+0.46%
More